Max Wygod is a healthcare executive and investor with years of experience investing, acquiring and divesting public and private growth companies at the intersection of healthcare and information technology. Max leads the investment strategy for Wygod & Co. LLC, a virtual family office dedicated to private and public investments in the healthcare industry. The organization works with a group of successful healthcare managers and investors that have been colleagues and partners with Max’s father, Marty Wygod, over his 50 years in the industry. Marty has successfully led seven public companies, primarily in early stage. The appreciation in value of Marty’s companies to public investors has been over $15 billion. He has worked with their directors and management to provide strategic direction to differentiate them from their competitors and enhance their value in the public markets, culminating with the sale of WebMD to a KKR portfolio company for $2.8 billion.
Previously, Max served as a Vice President of Business Development at WebMD Health, where he participated in facilitating its sale to KKR. A seven-year veteran at WebMD, Max had various business development and operating roles that included, but not limited to, WebMD’s strategic growth objectives through capital allocation, acquisitions, partnerships, joint ventures, commercial relationships, investments and divestitures.
Max received a BA from Duke University and an MBA from The Stern School at New York University.
Current role